This protocol addresses craniopharyngioma management specifically in adult patients aged 18 years or older. Craniopharyngioma has a bimodal age distribution — with a first incidence peak in children (ages 5–10) and a second peak in adults (ages 55–69) — making a dedicated adult-focused approach clinically distinct.
Adults (age 18 years or older) with a confirmed diagnosis of craniopharyngioma, including those at initial presentation and those presenting with recurrence where prior radiotherapy has not been administered.
The evidence-based strategy for this population centres on a conformal radiotherapy approach — utilising intensity modulation — typically applied in the context of surgical management. This approach may also be relevant in certain recurrence settings. The complete regimen, sequencing, and individualised parameters are contained in the full structured protocol.